Zone diet validation studies

Every now and then it’s worth going back over the published literature to see how the Zone diet stacks up in various areas of nutritional research.

The dangers of over-analyzing too much data in prostate study

In the last week there has been a constant buzz about an online pre-publication of a new research article that suggests that high concentrations of omega-3 fatty acids promote aggressive prostate cancer. Well, that really isn’t the case, in spite of the press reports.

Obesity starts in the womb

A new study from Harvard Medical School strongly suggests that childhood obesity begins in the mother’s womb.

Fetal programming: Gene transformation gone wild (Part II)

In part 1 of this blog, I discussed how dietary changes can alter gene expression and how those epigenetic changes can be mediated from one generation to the next by fetal programming. This is very clear from animal studies.

Omega-3 fatty acids and blood pressure

It was recognized many years ago that fish oil has a dose-dependent effect on lowering blood pressure. So how does it do it? There are a lot of different ways.

High purity omega-3 oil doesn’t work if you don’t take enough

On Aug. 29, the New England Journal of Medicine published an electronic article stating that giving supplements of EPA and DHA to people with a prior heart attack had no benefits on preventing future cardiovascular events (1). Of course, this article states the reason is that current drugs the patients are receiving are so good… Read more »

The Mood-lifting properties of B-vitamins

In a previous blog we addressed the impact of omega-3 fatty acids and their mood-lifting properties, and now it looks like we can add certain B-vitamins to the list. A recent publication in the American Journal of Clinical Nutrition looked at whether dietary intakes of vitamin B-6, B-12 and folate had an association with depressive… Read more »

High purity omega-3 oil may be alternative to anti-psychotic drugs

The risks of anti-psychotic medications are well documented especially in young adults, making safer alternatives highly desired. A study published this month in the Archives of General Psychiatry shows promise for individuals with psychotic disorders, such as schizophrenia (1). In a double-blind, placebo-controlled trial (the gold standard), 81 individuals 13-25 years of age were randomized… Read more »